Grant Gordon and other administration members are simply trying to distract the shareholders that Cardiovascular Biotherapeutics/Venturis Therapeutics has zero value whatsoever. As the lawyer said so clearly in US Federal Court records: CVBT/VT has no assets and no revenue stream.